Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478699
Status:
COMPLETED
Last Update Posted:
2015-07-07
First Post:
2007-05-24
Brief Title:
Randomized Customized Adjuvant Chemotherapy GECP-SCAT
Sponsor:
Spanish Lung Cancer Group
Organization:
Spanish Lung Cancer Group
Study Overview
Official Title:
Phase III Open Multicenter and Randomized Study of Customized Adjuvant Chemotherapy Based on BRCA1 mRNA Levels in Completely Resected Stages II-IIIA Non-Small-Cell Lung Cancer Patients
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GECP-SCAT
Brief Summary:
Randomized Study of Customized Adjuvant Chemotherapy based on BRCA1 mRNA Levels in Completely Resected stages II-IIIA Non-Small-Cell Lung Cancer Patients
Detailed Description:
Randomized phase III predictive pharmacogenomic open prospective international multicenter study in patients with non-small-cell lung carcinoma NSCLC after complete resection and with N1 or N2 involvement
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT Code 2007-000067-15 | None | None | None |